AI screening for early cancer detection on routine chest-abdomen-pelvis CT
Part of Cancer clinical trials.
This study tests whether artificial intelligence (AI) can help doctors spot early signs of cancer (breast, liver, kidney, or bladder) on routine CT scans that patients get for other reasons. The goal is to see if this 'opportunistic screening' catches cancers earlier when they may be easier to treat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with and treated for cancer (breast, liver, kidney, or bladder) at this institution
- You have a CT scan of your chest, abdomen, and pelvis taken before starting cancer treatment
- Your CT scan images are clear enough to read and show the full area being studied, without excessive metal or motion blur
- Your medical records include complete information about your diagnosis and treatment
- You do not have other major health conditions that would make participation unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This trial uses artificial intelligence to analyze routine CT scans of the chest or abdomen (done for other reasons) to detect early signs of pancreatic cancer. If you are already getting a CT scan for another health issue, this could help catch pancreatic cancer early without extra tests.
This trial uses artificial intelligence (AI) to analyze standard, non-contrast CT scans to identify and understand kidney tumors. It aims to help doctors make better decisions without needing special dye injections.
This study tests whether an AI tool can help doctors read CT scans of the liver to find cancerous spots. If you have had a CT scan of your abdomen with specific timing, you might be able to join.
This trial uses artificial intelligence (AI) to look at chest CT scans for signs of coronary artery disease. It may help find blockages without needing a separate heart-specific CT scan.
Hear when a new Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.